Product/Composition:- | Deferasirox |
---|---|
Strength:- | 125 mg, 250 mg, 500 mg |
Form:- | Tablets for Oral Suspension |
Reference Brands:- | Exjade, Jadenu (film-coated) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Deferasirox treats transfusion-related iron overload. Available as Exjade and Jadenu in multiple strengths. Suitable for global pharma B2B supply.
Deferasirox is a leading oral iron chelation therapy used to manage chronic iron overload in patients receiving long-term blood transfusions, such as those with thalassemia or sickle cell disease. It is available as 125 mg, 250 mg, and 500 mg tablets for oral suspension, and 90 mg, 180 mg, and 360 mg film-coated tablets (JadenuĀ®). Trusted brands like Exjade and Jadenu are approved in the US and EU. Deferasirox is manufactured in GMP-certified facilities and is ideal for pharma B2B distribution, including hospitals, clinics, and global buyers. Contact us for bulk export and regulatory support.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications